课题基金 / 基金详情

EPITOPE MAPPING OF ANTIBODIES TO VON WILLEBRAND FACTOR

EPITOPE MAPPING OF ANTIBODIES TO VON WILLEBRAND FACTOR
血管性血友病因子抗体的表位作图
批准号:
3792657
负责人:
W FRICKE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

W FRICKE的其他基金

相似基金

相关文献

中文摘要
翻译
两名von Willebrand因子抗体阳性患者的血浆 正在研究确定von Willebrand因子的表位,这些表位是 被抗体识别。一般的方法是 用酶法切割VWF,然后免疫沉淀 使用患者免疫球蛋白共价偶联到蛋白A的片段- 琼脂糖珠。凝血酶消化VWF后,大量 产生大小从约176kD到40kD的片段。 使用毛驴多克隆抗体的初步实验还没有 成功地免疫沉淀了任何VWF碎片。目前还不清楚 为什么,但可能的解释包括 消化和蛋白质不足,无法通过免疫印迹检测。 来自两名具有VWF抗体的患者的血浆将用于这些 研究什么时候VWF片段可以 用这种方法进行免疫沉淀。
英文摘要
Plasma from two patients with antibodies to von Willebrand factor are being studied to identify the epitopes on von Willebrand factor that are recognized by the antibodies. The general approach has been to enzymatically cleave vWf and then immunoprecipitate the resulting fragments using patient immunoglobulin covalently coupled to protein A - Sepharose beads. Following digestion of vWf by thrombin, numerous fragments ranging in size from about 176 kD to 40 kD are generated. Preliminary experiments using a burro polyclonal antibody have not been sucessful in immunoprecipitating any vWf fragments. It is unclear as to why, but possible explanations include destruction of the epitopes by digestion and insufficient protein to be detected by immunoblotting. Plasma from two patients with antibodies to vWf will be used in these studies when it is clear that the vWf fragments can be immunoprecipitated by this method.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTIVATION OF FVIII BY FXA AND INHIBITION BY TISSUE FACTOR PATHWAY INHIBITOR
EPITOPE MAPPING OF ANTIBODIES TO FACTOR VIII
EPITOPE MAPPING OF FACTOR VIII AND VON WILLEBRAND FACTOR
  • 批准号:
    3770445
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    W FRICKE
  • 依托单位:
    --
EFFECT OF FACTOR XIA ON FACTOR VIII
  • 批准号:
    3770444
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    W FRICKE
  • 依托单位:
    --
海外基金